BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
76.80
-0.56 (-0.72%)
At close: Nov 17, 2026, 4:00 PM EST
76.76
-0.04 (-0.05%)
After-hours: Nov 17, 2026, 5:52 PM EST

BridgeBio Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
14,96114,7405,1867,0231,1392,455
Market Cap Growth
16.94%184.24%-26.16%516.57%-53.61%-71.83%
Enterprise Value
16,80016,8016,6618,2292,2713,264
Last Close Price
77.3676.4927.4440.377.6216.68

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.7529.3623.37754.9214.6735.22
PB Ratio
--7.10-3.56-5.23-0.91-2.84

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
17.7033.4630.02884.5129.2546.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-2.04-0.90-1.19-1.30-1.38-1.99
Net Debt / Equity Ratio
-1.11-0.61-0.72-0.97-1.00-1.03
Net Debt / EBITDA Ratio
-5.28-2.57-1.84-2.20-2.71-1.57
Net Debt / FCF Ratio
-4.97-2.85-2.01-2.47-2.95-1.74
Asset Turnover
0.600.540.300.020.100.08
Quick Ratio
1.962.524.443.044.036.34
Current Ratio
2.092.774.673.324.526.58
Return on Assets (ROA)
-13.97%-33.83%-49.24%-64.08%-35.80%-41.75%
Return on Capital Employed (ROCE)
-29.80%-77.50%-75.50%-148.90%-93.40%-65.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.95%-4.92%-10.33%-9.16%-42.24%-22.91%
FCF Yield
-2.48%-3.03%-10.06%-7.53%-37.25%-20.82%
Buyback Yield / Dilution
-2.39%-2.93%-14.30%-10.39%-2.16%-22.34%
SEC Filings: 10-K · 10-Q